| Item Type | Name |
|
Academic Article
|
Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Academic Article
|
Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
|
|
Academic Article
|
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
|
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
|
Academic Article
|
Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature.
|
|
Academic Article
|
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer.
|
|
Academic Article
|
Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.
|
|
Academic Article
|
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.
|
|
Academic Article
|
Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer.
|
|
Academic Article
|
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
|
|
Academic Article
|
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors.
|
|
Academic Article
|
Irinotecan in the management of patients with pancreatic cancer.
|
|
Academic Article
|
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
|
|
Academic Article
|
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.
|
|
Academic Article
|
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
|
|
Academic Article
|
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
|
|
Academic Article
|
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
|
|
Academic Article
|
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
|
|
Academic Article
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
|
|
Academic Article
|
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
|
|
Academic Article
|
A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors.
|
|
Academic Article
|
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
|
|
Academic Article
|
Irinotecan and gemcitabine in patients with solid tumors: phase I trial.
|
|
Academic Article
|
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
|
|
Academic Article
|
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
|
|
Academic Article
|
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
|
|
Academic Article
|
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.
|
|
Academic Article
|
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
|
|
Academic Article
|
Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer.
|
|
Academic Article
|
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
|
|
Academic Article
|
A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
|
|
Academic Article
|
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
|
|
Academic Article
|
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
|
|
Academic Article
|
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
|
|
Academic Article
|
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
|
|
Academic Article
|
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
|
|
Academic Article
|
Cancer Leukemia Group B. Random Phase II trial of Gemcitabine and docetaxel or Irinotecan and Gemcitabine in advanced or metastatic NSCLC
|